₹-19.55
(Market cap
₹6,199 Cr
Revenue (TTM)
₹2,171 Cr
P/E Ratio
22
P/B Ratio
2.5
Div. Yield
0 %
Quality Score
9/10
Growth Score
7/10
Valuation Score
5/10
Momentum Score
4/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹281 Cr
-
ROE
12.2 %
-
ROCE
16.5 %
-
Industry P/E
35.23
-
EV/EBITDA
13.4
-
Debt to Equity
0
-
Book Value
₹152.6
-
EPS
₹18.3
-
Face value
1
-
Shares outstanding
162,810,084
10 Years Aggregate
CFO
₹1,903.42 Cr
EBITDA
₹2,723.52 Cr
Net Profit
₹2,223.42 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
FDC
| -10.0 | 2.5 | 2.6 | -12.9 | 8.7 | 2.5 | 7.6 |
|
BSE Healthcare
| 8.0 | 3.6 | 8.8 | 9.9 | 24.9 | 13.6 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
FDC
| -17.2 | 26.7 | 46.4 | -11.0 | -8.6 | 56.1 | 22.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
FDC
|
381.0 | 6,199.0 | 2,170.9 | 281.4 | 12.6 | 12.1 | 22 | 2.5 |
| 2,976.5 | 37,200.8 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 35.2 | 8.2 | |
| 8,600.0 | 21,496.5 | 2,275.6 | 187.5 | 10.3 | 22.9 | 114.6 | 24.6 | |
| 2,033.1 | 15,441.4 | 2,187.2 | 649.7 | 31.5 | 19 | 24.1 | 4.3 | |
| 1,365.2 | 18,859.7 | 3,129.4 | 647.4 | 26.9 | 18.1 | 30.4 | 4.8 | |
| 2,169.3 | 34,833.2 | 4,147.8 | 709.5 | 22.3 | 19.1 | 49.1 | 8.4 | |
| 4,456.3 | 20,381.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.2 | 4.8 | |
| 6,200.0 | 10,245.6 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31.3 | 19.5 | |
| 538.1 | 10,497.9 | 1,538.1 | 226.2 | 20.4 | 9 | 43.1 | 4.1 | |
| 1,044.6 | 9,613.2 | 4,858.7 | 574.1 | 14.9 | 19.7 | 17.3 | 3.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Dhruv Singhvi
About FDC
FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including... anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India. Read more
-
Incorporated
1940
-
Chairman
--
-
Managing Director
Mohan A Chandavarkar
-
Headquarters
Chhatrapati Sambhajinagar - (Aurangabad), Maharashtra
-
Website
Looking for more details about FDC Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsAnnouncement Under Regulation 30 - ANDA Approval
18-May-2026No News & Announcements are available.
FAQs for FDC
What is the current share price of FDC Ltd Today?
The share price of FDC Ltd is ₹381.00 (NSE) and ₹380.75 (BSE) as of 05-Jun-2026 IST. FDC Ltd has given a return of 8.65% in the last 3 years.
What is the current PB & PE ratio of FDC Ltd?
The P/E ratio of FDC Ltd is 22.03 times as on 05-Jun-2026, a 37 discount to its peers’ median range of 35.23 times.
The P/B ratio of FDC Ltd is 2.49 times as on 05-Jun-2026, a 46 discount to its peers’ median range of 4.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
24.06
|
2.81
|
|
2024
|
22.66
|
3.30
|
|
2023
|
21.94
|
2.15
|
|
2022
|
20.04
|
2.22
|
|
2021
|
16.00
|
2.78
|
What is the 52 Week High and Low of FDC Ltd?
The 52-week high and low of FDC Ltd are Rs 527.80 and Rs 312.95 as of 08-Jun-2026.
What is the market cap of FDC Ltd?
FDC Ltd has a market capitalisation of ₹ 6,199 Cr as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in FDC Ltd?
Before investing in FDC Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.